This study, titled 'Virtual HDR(sm) CyberKnife Radiosurgery for Localized Prostatic Carcinoma: Dosimetry Comparison with HDR Brachytherapy and Preliminary Clinical Observations' supports the CyberKnife System's clinical flexibility and demonstrates its capability to create either a uniform distribution of radiation across the prostate or a pattern of dose that is similar to HDR brachytherapy. The System's ability to track the location of the prostate, detect its position and correct the treatment beam angle continually throughout treatment ensures that either type of plan can be delivered accurately, accounting for the motion of the prostate during the treatment. The CyberKnife System gives clinicians a variety of non-invasive treatment delivery options, allowing them to customize the treatment to each patient's specific case.
"We are pleased to have published support of the CyberKnife System's diverse capabilities in prostate cancer planning and look forward to further clinical evidence following the publication of long term follow-up studies," said Eric P. Lindquist., senior vice president and chief marketing officer of Accuray.
Explanation of HDR Brachytherapy
HDR brachytherapy is a procedure commonly used in the treatment of
prostate cancer. The procedure involves the insertion of catheters into the
prostate gland, and then the delivery of a series of radiation treatments
through these catheters. A computer-controlled machine forces a seed
containing a high energy radioactive source into the catheters one at a
time, and then controls how long this seed remains in each of the
catheters. This method allows different regions of the prostate to receive
|SOURCE Accuray Incorporated|
Copyright©2008 PR Newswire.
All rights reserved